Skip to Content

'Gold Standard' Clinical Trial Finds Hydroxychloroquine Won't Prevent COVID-19

WEDNESDAY, June 3, 2020 -- Hydroxychloroquine, the malaria drug touted and reportedly used by President Donald Trump as a preventative for COVID-19, appears not to have lived up to its hype, a new study shows.

Unlike some prior studies, this new trial was a "gold standard" prospective, randomized clinical trial. It found that hydroxychloroquine could not prevent COVID-19 any better than a sugar pill.

Worse, 40% of those taking hydroxychloroquine developed side effects including nausea, upset stomach or diarrhea. Fortunately, no serious side effects or heart problems occurred in the study, the researchers noted. An uptick in risk for potentially dangerous heart rhythm abnormalities had been noted in prior studies in which COVID-19 patients received hydroxychloroquine as a treatment.

For the trial, researchers randomly assigned more than 800 people in the United States and Canada to take hydroxychloroquine, or a placebo, for five days. All of the participants had been exposed to people with COVID-19.

Overall, 12% of those taking hydroxychloroquine developed COVID-19 as did 14% taking the placebo, the findings showed.

This finding was not statistically significant, the study authors noted.

"Our objective was to answer the question of whether hydroxychloroquine worked to prevent disease or did not work," said lead researcher Dr. David Boulware, an infectious disease doctor at the University of Minnesota.

"While we are disappointed that this did not prevent COVID-19, we are pleased that we were able to provide a conclusive answer," Boulware said in a university news release. "Our objective was to find an answer."

The report was published online June 3 in the New England Journal of Medicine.

Several other studies focused on the drug as a treatment have found it has no benefit and could possibly harm COVID-19 patients.

© 2021 HealthDay. All rights reserved.

Read this next

Any COVID-19 Infection Raises Odds for Lingering Symptoms, Study Finds

TUESDAY, May 11, 2021 -- Serious cases of "long-haul COVID-19" are rare in patients who were not hospitalized after their infection, but these patients still report more doctor or...

Most Severe COVID Cases Involve Neuro Issues, and They're More Often Fatal

TUESDAY, May 11, 2021 -- Neurological problems are occurring in a very high percentage of hospitalized COVID-19 patients — and what's worse, those symptoms foretell a bad...

Alcohol Is No Friend to Social Distancing

TUESDAY, May 11, 2021 -- Maintaining adequate social distance from strangers — a key COVID-19 preventive measure — can be tough when you're drinking alcohol,...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.